EPO Patents = 6

Trademarks = 2

Forward Citations = 1

Loading Chart...

5 inventors (with patents filed for the assignee):

Charlie Galle (4 out of 4 patents)

Joël Chavas (2 out of 3 patents)

Guillaume Chenegros (2 out of 10 patents)

4. Francesco Galluppi (2 out of 2 patents)

5. Benjamin R Benosman (1 out of 3 patents)

6. Guillaume Chenegros (3 patents)

7. Benjamin Benosman (0 patent)

6 patents: Sort by Forward Citations

1. 12741157 - Viewing apparatus and method for projecting a light signal (2026-09-22),

2. 12364875 - Viewing apparatus and method for projecting a light signal (2025-07-22),

3. 11986668 - Method for controlling an optogenetic device using filtering and associated devices (2024-05-21),

4. 11875545 - Method and device for processing asynchronous signals generated by an event-based light sensor (2024-01-16),

5. 11400311 - Device for illuminating an object with a controlled light intensity and associated method (2022-08-02),

6. 11320649 - Objective, camera and system adapted for optogenetics comprising such objective (2022-05-03),

Company Overview

Gensight Biologics is a biotechnology company focused on developing gene therapies for the treatment of genetic diseases affecting the eyes. The company's lead product candidate, GS010, is a gene therapy designed to treat Leber's hereditary optic neuropathy. Gensight Biologics is dedicated to advancing innovative treatments for patients with inherited retinal and neurodegenerative diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#502 in Paris

#2,491 in France

Paris, France

Gensight Biologics

Forward Citations = 1

5 inventors:

Charlie Galle (4 out of 4 patents)

Joël Chavas (2 out of 3 patents)

Guillaume Chenegros (2 out of 10 patents)

4. Francesco Galluppi (2 out of 2 patents)

5. Benjamin R Benosman (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gensight Biologics. Retrieved from https://idiyas.com/company/gensight-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]